We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-0.34%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$55.7B
AUM Growth
-$11.4B
Cap. Flow
-$9.72B
Cap. Flow %
-17.45%
Top 10 Hldgs %
9.49%
Holding
4,137
New
382
Increased
1,324
Reduced
1,495
Closed
773

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$397M
2
YHOO
Yahoo Inc
YHOO
+$342M
3
BAC icon
Bank of America
BAC
+$322M
4
C icon
Citigroup
C
+$260M
5
BKNG icon
Booking.com
BKNG
+$219M

Sector Composition

Rank Sector Weight
1 Healthcare 13.78%
2 Technology 11.11%
3 Financials 10%
4 Consumer Discretionary 8.83%
5 Communication Services 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFOP
3201
DELISTED
Alliance Fiber Optic Prod Inc
AFOP
$161K ﹤0.01%
10,885
-2,836
-21% -$39.3K
AUY
3202
DELISTED
Yamana Gold, Inc.
AUY
$160K ﹤0.01%
+52,645
New +$129K
SEAC
3203
DELISTED
Seachange International Inc
SEAC
$155K ﹤0.01%
1,404
+338
+32% +$39.2K
LCTX icon
3204
Lineage Cell Therapeutics
LCTX
$276M
$154K ﹤0.01%
61,385
+9,444
+18% +$21.1K
TVRD
3205
Tvardi Therapeutics
TVRD
$23.7M
$152K ﹤0.01%
678
-2,561
-79% -$765K
SRCI
3206
DELISTED
SRC Energy Inc
SRCI
$152K ﹤0.01%
+19,623
New +$132K
HOV icon
3207
Hovnanian Enterprises
HOV
$739M
$151K ﹤0.01%
3,864
-4,505
-54% -$170K
MTW icon
3208
Manitowoc
MTW
$710M
$150K ﹤0.01%
+8,635
New +$125K
TSEM icon
3209
Tower Semiconductor
TSEM
$23.9B
$150K ﹤0.01%
12,407
-51,958
-81% -$653K
ACHN
3210
DELISTED
Achillion Pharmaceuticals
ACHN
$148K ﹤0.01%
19,224
-92,290
-83% -$676K
ORC
3211
Orchid Island Capital
ORC
$1.34B
$147K ﹤0.01%
2,836
-3,805
-57% -$180K
CACQ
3212
DELISTED
Caesars Acquisition Company
CACQ
$145K ﹤0.01%
23,729
-879
-4% -$4.94K
JMBA
3213
DELISTED
Jamba, Inc.
JMBA
$145K ﹤0.01%
+11,720
New +$149K
BOX icon
3214
Box
BOX
$4.64B
$143K ﹤0.01%
+11,692
New +$133K
PALI icon
3215
Palisade Bio
PALI
$350M
0
TRVN
3216
DELISTED
Trevena, Inc.
TRVN
$142K ﹤0.01%
27
-9
-25% -$45.3K
CMO
3217
DELISTED
Capstead Mortgage Corp.
CMO
$138K ﹤0.01%
+13,950
New +$130K
BKCC
3218
DELISTED
BlackRock Capital Investment Corporation
BKCC
$135K ﹤0.01%
+14,356
New +$128K
YGE
3219
DELISTED
Yingli Green Energy Holding Comp
YGE
$133K ﹤0.01%
29,048
-18,471
-39% -$79.4K
PACD
3220
DELISTED
Pacific Drilling S A
PACD
$133K ﹤0.01%
27,196
-4,576
-14% -$21.9K
AMPE
3221
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$132K ﹤0.01%
195
+5
+3% +$3.37K
ATRS
3222
DELISTED
Antares Pharma, Inc.
ATRS
$132K ﹤0.01%
151,649
-25,497
-14% -$24.7K
CETV
3223
DELISTED
Central European Media Enterprises Ltd
CETV
$132K ﹤0.01%
51,796
+26,655
+106% +$65K
VMEM
3224
DELISTED
VIOLIN MEMORY, INC.
VMEM
$132K ﹤0.01%
63,288
+53,519
+548% +$154K
CGRN
3225
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$130K ﹤0.01%
8,137
+4,627
+132% +$61.2K

Similar funds

David Shaw's Q1 2016 Portfolio in Review

As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.

  • David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
  • David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
  • David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
  • David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
  • David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
  • David Shaw opened 382 new positions and closed 773 in Q1 2016.
  • David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.

Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.